Stocks · Korea 142280 KOSDAQ

GC Medical Science

4,200원 +26.89% Market cap 1,006억 2026-10-07 close
Data as of 2026-10-07 · Linked from 6 pages
An overview for this page is not available in English yet. The figures below are updated daily.

Key figures 2026-10-07 basis

PER24.85x
PBR2.06x
EPS169 KRW
BPS2,040 KRW
ROE9.46%
DPS0 KRW

Returns and 52-week range

1W+31.91%
1M+33.17%
3M+40.81%
6M+11.63%
1Y-1.07%
YTD+2.33%
52W high6,660원
52W low2,200원
From 52W high-37.31%

Financial results (consolidated)

PeriodRevenueOperating incomeNet incomeOP margin
20221,131억-13억-31억-1.1%
2023940억18억19억1.9%
20241,039억23억34억2.2%
20251,084억29억35억2.7%
Quarterly
2024 4Q278억10억21억3.5%
2025 1Q265억5억-7억1.9%
2025 2Q304억11억24억3.5%
2025 3Q264억9억14억3.6%
2025 4Q250억4억3억1.6%
2026 1Q236억3억2억1.2%

Company

CEO김연근
Founded2003-12-29
Fiscal year end12
Address: 경기도 용인시 기흥구 용구대로2469번길 15 2층

Peers in the same sector

CompanyMarket capP/EP/B1M
메타바이오메드1,016억8.540.81-3.10%
아스타994억—9.98+0.00%
동구바이오제약1,025억1.940.64+3.56%
한국파마985억—1.43+17.27%
세운메디칼1,027억8.410.65-3.50%
SCL사이언스969억—3.96+26.39%

Recent filings

Source: DART (Financial Supervisory Service electronic disclosure)

Recent news

Sources and notes

This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.